Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 4 (2007), Issue 10 (October)

1. The cognitive and neurophysiological basis of emotion dysregulation in bipolar disorder.
   J Affect Disord, 103(1): 29-42. [Abstract] [Full-text]
2. Lamotrigine therapy in elderly patients with epilepsy, bipolar disorder or dementia.
   Int J Geriatr Psychiatry, 22(10): 945-50. [Abstract] [Full-text]
3. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder.
   J Affect Disord, 103(1): 181-6. [Abstract] [Full-text]
4. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder.
   Int J Geriatr Psychiatry, 22(10): 992-8. [Abstract] [Full-text]
5. A preliminary longitudinal fMRI study of frontal-subcortical circuits in bipolar disorder using a paced motor activation paradigm.
   J Affect Disord, 103(1): 237-41. [Abstract] [Full-text]
6. No evidence for association between 19 cholinergic genes and bipolar disorder.
   Am J Med Genet B Neuropsychiatr Genet, 144(6): 715-23. [Abstract] [Full-text]
7. Soft neurological signs do not increase with age in euthymic bipolar subjects.
   J Affect Disord, 103(1): 99-103. [Abstract] [Full-text]
8. Genome-wide scan of bipolar disorder and investigation of population stratification effects on linkage: support for susceptibility loci at 4q21, 7q36, 9p21, 12q24, 14q24, and 16p13.
   Am J Med Genet B Neuropsychiatr Genet, 144(6): 791-801. [Abstract] [Full-text]
9. Bipolar pharmacotherapy and suicidal behavior. Part I: Lithium, divalproex and carbamazepine.
   J Affect Disord, 103(1): 5-11. [Abstract] [Full-text]
10. Bipolar pharmacotherapy and suicidal behavior Part 2. The impact of antidepressants.
    J Affect Disord, 103(1): 13-21. [Abstract] [Full-text]
11. Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics.
    J Affect Disord, 103(1): 23-8. [Abstract] [Full-text]
12. Association of distinct allelic haplotypes of DISC1 with psychotic and bipolar spectrum disorders and with underlying cognitive impairments.
    Hum Mol Genet, 16(20): 3517-28. [Abstract] [Full-text]
13. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Hum Psychopharmacol, 22(7): 469-76. [Abstract] [Full-text]
14. Heritability of cognitive functions in families with bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 144(6): 802-8. [Abstract] [Full-text]
15. Deaf client with bipolar illness: a case report.
    Clin Pract Epidemol Ment Health, 3(1): 19. [Abstract] [Full-text]
16. The expression of Troponin T1 gene is induced by ketamine in adult mouse brain.
    Brain Res, 1174: 7-17. [Abstract] [Full-text]
17. Association analysis of HSP90B1 with bipolar disorder.
    J Hum Genet, 52(10): 794-803. [Abstract] [Full-text]
18. The prevalence and significance of substance use disorders in bipolar type I and II disorder.
    Subst Abuse Treat Prev Policy, 2(1): 29. [Abstract] [Full-text]
19. The epidemiology of psychiatric disorders among repeat DUI offenders accepting a treatment-sentencing option.
    J Consult Clin Psychol, 75(5): 795-804. [Abstract] [Full-text]
20. Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.
    Biol Psychiatry, 62(8): 934-43. [Abstract] [Full-text]
21. Progressive gray matter loss in patients with bipolar disorder.
    Biol Psychiatry, 62(8): 894-900. [Abstract] [Full-text]
22. The neurocognitive signature of psychotic bipolar disorder.
    Biol Psychiatry, 62(8): 910-6. [Abstract] [Full-text]
23. Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.
    Biol Psychiatry, 62(8): 870-7. [Abstract] [Full-text]
24. Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia.
    Biol Psychiatry, 62(8): 884-93. [Abstract] [Full-text]
25. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity.
    Neuroscience, 149(1): 203-212. [Abstract] [Full-text]
26. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression.
    Biol Psychiatry, 62(8): 917-24. [Abstract] [Full-text]
27. Quetiapine for the continuation treatment of bipolar depression: naturalistic prospective case series from the Stanley Bipolar Treatment Network.
    Int Clin Psychopharmacol, 22(6): 376-81. [Abstract] [Full-text]
28. Differential alterations of kainate receptor subunits in inhibitory interneurons in the anterior cingulate cortex in schizophrenia and bipolar disorder.
    Schizophr Res, 96(1): 46-61. [Abstract] [Full-text]
29. Recent understandings in geriatric affective disorder.
    Curr Opin Psychiatry, 20(6): 539-43. [Abstract] [Full-text]
30. Psychiatric disorders in advanced cancer.
    Cancer, 110(8): 1665-76. [Abstract] [Full-text]
31. Oxcarbazepine as monotherapy of acute mania in insufficiently controlled type-1 Diabetes Mellitus: a case-report.
    Ann Gen Psychiatry, 6(1): 25. [Abstract] [Full-text]
32. Increased anterior cingulate cortex volume in bipolar I disorder.
    Aust N Z J Psychiatry, 41(11): 910-6. [Abstract] [Full-text]
33. Next generation of self-management education: Web-based bipolar disorder program.
    Aust N Z J Psychiatry, 41(11): 903-9. [Abstract] [Full-text]
34. The first genomewide interaction and locus-heterogeneity linkage scan in bipolar affective disorder: strong evidence of epistatic effects between loci on chromosomes 2q and 6q.
    Am J Hum Genet, 81(5): 974-86. [Abstract] [Full-text]
35. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
    Mol Psychiatry. [Abstract] [Full-text]
36. The effects of a neuregulin 1 variant on white matter density and integrity.
    Mol Psychiatry. [Abstract] [Full-text]
37. Treatment of bipolar disorder: a complex treatment for a multi-facet disorder.
    Ann Gen Psychiatry, 6(1): 27. [Abstract] [Full-text]
38. Physical activity and prevalence and incidence of mental disorders in adolescents and young adults.
    Psychol Med, 37(11): 1657-66. [Abstract] [Full-text]
39. Clinical and prognostic implications of seasonal pattern in bipolar disorder: a 10-year follow-up of 302 patients.
    Psychol Med, 37(11): 1595-9. [Abstract] [Full-text]
40. Attitudes towards childbearing, causal attributions for bipolar disorder and psychological distress: a study of families with multiple cases of bipolar disorder.
    Psychol Med, 37(11): 1601-11. [Abstract] [Full-text]
41. Mindfulness training assists individuals with moderate mental retardation to maintain their community placements.
    Behav Modif, 31(6): 800-14. [Abstract] [Full-text]
42. Prominent synaptic and metabolic abnormalities revealed by proteomic analysis of the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder.
    Mol Psychiatry. [Abstract] [Full-text]
43. Psychiatric issues in multiple sclerosis.
    Psychiatr Clin North Am, 30(4): 803-17. [Abstract] [Full-text]
44. Family interventions for bipolar disorder.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
45. Comparing adherence to and persistence with antipsychotic therapy among patients with bipolar disorder.
    Ann Pharmacother, 41(11): 1812-8. [Abstract] [Full-text]
46. Differences in agonist/antagonist properties at human dopamine D(2) receptors between aripiprazole, bifeprunox and SDZ 208-912.
    Eur J Pharmacol, 574(2): 103-11. [Abstract] [Full-text]
47. Positive mood and sleep disturbance in acquired mania following temporal lobe damage.
    Brain Inj, 21(11): 1209-15. [Abstract] [Full-text]
48. Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample.
    J Psychiatr Res, 42(1): 35-40. [Abstract] [Full-text]
49. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Compr Psychiatry, 48(6): 583-91. [Abstract] [Full-text]
50. Eating disorders and illness burden in patients with bipolar spectrum disorders.
    Compr Psychiatry, 48(6): 516-21. [Abstract] [Full-text]
51. TGFB-induced factor (TGIF): a candidate gene for psychosis on chromosome 18p.
    Mol Psychiatry, 12(11): 1033-41. [Abstract] [Full-text]
52. Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex.
    Mol Psychiatry, 12(11): 1001-10. [Abstract] [Full-text]
53. Association analysis of the chromosome 4p15-p16 candidate region for bipolar disorder and schizophrenia.
    Mol Psychiatry, 12(11): 1011-25. [Abstract] [Full-text]
54. Enhancement by lithium of cAMP-induced CRE/CREB-directed gene transcription conferred by TORC on the CREB basic leucine zipper domain.
    Biochem J, 408(1): 69-77. [Abstract] [Full-text]
55. The use of antipsychotics in children and adolescents with bipolar disorders.
    Expert Opin Pharmacother, 8(16): 2673-87. [Abstract] [Full-text]
56. EIF2B and Oligodendrocyte Survival: Where Nature and Nurture Meet in Bipolar Disorder and Schizophrenia?
    Schizophr Bull, 33(6): 1343-53. [Abstract] [Full-text]
57. No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population.
    Neurosci Lett, 427(1): 1-5. [Abstract] [Full-text]
58. Dopamine transporter genotype influences N-acetyl-aspartate in the left putamen.
    World J Biol Psychiatry. [Abstract] [Full-text]
59. Association analysis of exon III and exon I polymorphisms of the dopamine D4 receptor locus in Mexican psychotic patients.
    Psychiatry Res, 153(3): 209-15. [Abstract] [Full-text]
60. Durability of antidepressant response to vagus nerve stimulation (VNS).
    Int J Neuropsychopharmacol, 10(6): 817-26. [Abstract] [Full-text]
61. Enantioselective HPLC-UV method for determination of eslicarbazepine acetate (BIA 2-093) and its metabolites in human plasma.
    Biomed Chromatogr, 21(11): 1127-34. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.